跳转至内容
Merck
CN

03000590

人参皂苷Re

primary reference standard

别名:

(3β,6α,12β)-20-(β-D-葡萄糖基吡喃糖基氧基)-3,12-二羟基达玛-24-烯-6-基 2-O-(6-脱氧-α-L-甘露吡喃糖基)-β-D-吡喃葡萄糖苷, NSC 308877, 三七皂苷Re, 人参皂苷B2, 人参皂苷Re, 竹节参皂苷IVc

登录查看公司和协议定价

选择尺寸


关于此项目

经验公式(希尔记法):
C48H82O18
化学文摘社编号:
分子量:
947.15
UNSPSC代码:
85151701
NACRES:
NA.24
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

等级

primary reference standard

保质期

limited shelf life, expiry date on the label

制造商/商品名称

HWI

应用

food and beverages

SMILES字符串

CC1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O[C@H]3C[C@]4(C)[C@H](C[C@@H](O)[C@@H]5[C@H](CC[C@@]45C)[C@](C)(CC\C=C(/C)C)O[C@@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)[C@@]7(C)CC[C@H](O)C(C)(C)[C@H]37)[C@H](O)[C@H](O)[C@H]1O

InChI

1S/C48H82O18/c1-21(2)11-10-14-48(9,66-42-38(60)35(57)32(54)26(19-49)63-42)23-12-16-46(7)30(23)24(51)17-28-45(6)15-13-29(52)44(4,5)40(45)25(18-47(28,46)8)62-43-39(36(58)33(55)27(20-50)64-43)65-41-37(59)34(56)31(53)22(3)61-41/h11,22-43,49-60H,10,12-20H2,1-9H3/t22-,23-,24+,25-,26+,27+,28?,29-,30+,31-,32+,33+,34+,35?,36-,37+,38+,39+,40-,41-,42-,43+,45+,46+,47+,48-/m0/s1

InChI key

PWAOOJDMFUQOKB-QVPADXGFSA-N

正在寻找类似产品? 访问 产品对比指南

一般描述

Produced and qualified by HWI pharma services GmbH.
Exact content by quantitative NMR can be found on the certificate.

应用

Reference Standard in the analysis of herbal medicinal products

其他说明

This compound is commonly found in plants of the genus: panax

象形图

Exclamation mark

警示用语:

Warning

危险声明

危险分类

Acute Tox. 4 Oral

储存分类代码

11 - Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Fei Su et al.
Vaccine, 30(27), 4106-4112 (2012-04-05)
Previous studies have demonstrated that ginsenosides Rg1 and Re extracted from the root of Panax ginseng C.A. Meyer have adjuvant properties. However, the molecular mechanisms behind their adjuvant activities remain unclear. In the present study, we first investigated the adjuvant
Souren Paul et al.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 50(5), 1354-1361 (2012-03-10)
This study was undertaken to evaluate the effect of ginsenoside-Re (Gin-Re) isolated from roots of Panax ginseng on carrageenan-induced paw and TPA-induced skin inflammations in experimental mice. Moreover, to confirm further the anti-inflammatory activities of Gin-Re, LPS-induced macrophage activation model
Hai-Yan Quan et al.
International journal of molecular medicine, 29(1), 73-80 (2011-10-06)
Ginsenoside Re is a protopanaxatriol-type saponin isolated from Panax ginseng berry. Although anti-diabetic and anti-hyperlipidemic effects of Re have been reported by several groups, its mechanism of action is largely unknown until now. Here, we examine anti-diabetic and anti-hyperlipidemic activities
Dan Lu et al.
Journal of ethnopharmacology, 144(3), 656-663 (2012-10-16)
Ginseng has been widely used for hundreds of years in both China and other countries. It is well accepted that the pharmacological effects of ginseng are attributed to ginsenosides. Ginsenoside Re is one of the active ingredients in ginseng. The
Woojung Lee et al.
Food chemistry, 135(4), 2430-2435 (2012-09-18)
Ginsenoside Re, one of the major triol type ginsenosides contained in Panax ginseng, has a hydrophobic four-ring steroid-like structure with hydrophilic sugar moieties at carbon-3 and -20. The aim of the present study was to identify the changes in structure

商品

Optimize HPLC method for ginsenoside separation using a mixture, applying it to American Ginseng root, with conditions and chromatograms shown.

相关内容

Quantitative NMR for Content Assignment of Phytochemical Reference Standards

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持